Genetic Polymorphism in CYP2D6 and its Association with the Safety and Efficacy of Fluvoxamine in Patients with Major Depressive Disorder . (2023). Precision Medicine Communications, 3(1), 43-49. https://doi.org/10.55627/pmc.003.01.0301